Precision Biosciences (DTIL) Free Cash Flow (QoQ) (2018 - 2026)
Precision Biosciences (DTIL) Free Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 181.80 Mn | 153.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.09% |
| Dec 31, 2025 | 26.20% |
| Sep 30, 2025 | 24.68% |
| Jun 30, 2025 | -6.05% |
| Mar 31, 2025 | -1.79% |
| Dec 31, 2024 | -215.58% |
| Sep 30, 2024 | 60.05% |
| Jun 30, 2024 | 21.87% |
| Mar 31, 2024 | -127.07% |
| Dec 31, 2023 | 64.24% |
| Sep 30, 2023 | -5.71% |
| Jun 30, 2023 | 30.56% |
| Mar 31, 2023 | -42.31% |
| Dec 31, 2022 | -179.99% |
| Sep 30, 2022 | 212.37% |
| Jun 30, 2022 | 15.79% |
| Mar 31, 2022 | -17.88% |
| Dec 31, 2021 | -2.22% |
| Sep 30, 2021 | 25.40% |
| Jun 30, 2021 | -149.34% |